SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001372514-24-000052
Filing Date
2024-05-10
Accepted
2024-05-10 06:59:02
Documents
5
Effectiveness Date
2024-05-10

Document Format Files

Seq Description Document Type Size
1 S-8 kiorapharmaceuticalsinc-sx.htm S-8 99275
2 EX-FILING FEES exhibit107-filingfeetable.htm EX-FILING FEES 24922
3 EX-5.1 exhibit51-legalopinionblan.htm EX-5.1 9479
4 EX-23.1 exhibit231-auditorconsenthw.htm EX-23.1 3594
5 EX-23.2 exhibit232-auditorconsentea.htm EX-23.2 3608
  Complete submission text file 0001372514-24-000052.txt   142053
Mailing Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024
Business Address 332 ENCINITAS BOULEVARD SUITE 102 ENCINITAS CA 92024 781-788-8869
KIORA PHARMACEUTICALS INC (Filer) CIK: 0001372514 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-279296 | Film No.: 24932824
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)